Laviana Pharma

Contract development services provider

placeBeijing, Beijing, China calendar_todayFounded 2005 language lavianacorp.com

Innovation

57 patent families (37 granted) — focus: Chemistry & metallurgy, Human necessities, Operations & transport, Emerging technologies; filing pace accelerating. Cited 72 times.

YearFilings
20186
20192
202010
202113
20224
202417
20255

Investor mix

5 investors on record; lead investors include Huayi Capital, LYFE Capital, V-Capital.

Investor typeCountShare
Venture capital360%
Private equity240%
Coming soon